Anderson M S, Robertson A D, Macher I, Raetz C R
Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin, Madison 53706.
Biochemistry. 1988 Mar 22;27(6):1908-17. doi: 10.1021/bi00406a017.
The lipid A disaccharide of the Escherichia coli envelope is synthesized from the two fatty acylated glucosamine derivatives UDP-N2,O3-bis[(R)-3-hydroxytetradecanoyl]-alpha-D- glucosamine (UDP-2,3-diacyl-GlcN) and N2,O3-bis[(R)-3-hydroxytetradecanoyl]-alpha-D-glucosamine 1-phosphate (2,3-diacyl-GlcN-1-P) [Ray, B. L., Painter, G., & Raetz, C. R. H. (1984) J. Biol. Chem. 259, 4852-4859]. We have previously shown that UDP-2,3-diacyl-GlcN is generated in extracts of E. coli by fatty acylation of UDP-GlcNAc, giving UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc as the first intermediate, which is rapidly converted to UDP-2,3-diacyl-GlcN [Anderson, M. S., Bulawa, C. E., & Raetz, C. R. H. (1985) J. Biol. Chem. 260, 15536-15541; Anderson, M. S., & Raetz, C. R. H. (1987) J. Biol. Chem. 262, 5159-5169]. We now demonstrate a novel enzyme in the cytoplasmic fraction of E. coli, capable of deacetylating UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc to form UDP-3-O-[(R)-3-hydroxymyristoyl]glucosamine. The covalent structure of the previously undescribed UDP-3-O-[(R)-3-hydroxymyristoyl] glucosamine intermediate was established by 1H NMR spectroscopy and fast atom bombardment mass spectrometry. This material can be made to accumulate in E. coli extracts upon incubation of UDP-3-O-[(R)-3- hydroxymyristoyl]-GlcNAc in the absence of the fatty acyl donor [(R)-3-hydroxymyristoyl]-acyl carrier protein. However, addition of the isolated deacetylation product [UDP-3-O-[(R)-3-hydroxymyristoyl] glucosamine] back to membrane-free extracts of E. coli in the presence of [(R)-3-hydroxymyristoyl]-acyl carrier protein results in rapid conversion of this compound into the more hydrophobic products UDP-2,3-diacyl-GlcN, 2,3-diacyl-GlcN-1-P, and O-[2-amino-2-deoxy-N2,O3- bis[(R)-3-hydroxytetradecanoyl]-beta-D-glucopyranosyl]-(1----6)-2-amino- 2-deoxy-N2,O3-bis[(R)-3-hydroxytetradecanoyl]-alpha-D- glucopyranose 1-phosphate (tetra-acyldisaccharide-1-P), demonstrating its competency as a precursor. In vitro incubations using [acetyl-3H]UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc confirmed release of the acetyl moiety in this system as acetate, not as some other acetyl derivative. The deacetylation reaction was inhibited by 1 mM N-ethylmaleimide, while the subsequent N-acylation reaction was not. Our observations provide strong evidence that UDP-3-O-[(R)-3-hydroxymyristoyl]glucosamine is a true intermediate in the biosynthesis of UDP-2,3-diacyl-GlcN and lipid A.
大肠杆菌包膜中的脂多糖A二糖是由两种脂肪酰化葡糖胺衍生物合成的,即UDP-N2,O3-双[(R)-3-羟基十四烷酰基]-α-D-葡糖胺(UDP-2,3-二酰基-GlcN)和N2,O3-双[(R)-3-羟基十四烷酰基]-α-D-葡糖胺1-磷酸(2,3-二酰基-GlcN-1-P)[Ray, B. L., Painter, G., & Raetz, C. R. H. (1984) J. Biol. Chem. 259, 4852 - 4859]。我们之前已经表明,UDP-2,3-二酰基-GlcN是在大肠杆菌提取物中通过UDP-GlcNAc的脂肪酰化产生的,首先生成UDP-3-O-[(R)-3-羟基肉豆蔻酰基]-GlcNAc作为中间产物,然后迅速转化为UDP-2,3-二酰基-GlcN [Anderson, M. S., Bulawa, C. E., & Raetz, C. R. H. (1985) J. Biol. Chem. 260, 15536 - 15541; Anderson, M. S., & Raetz, C. R. H. (1987) J. Biol. Chem. 262, 5159 - 5169]。我们现在证明,在大肠杆菌的细胞质部分存在一种新型酶,它能够使UDP-3-O-[(R)-3-羟基肉豆蔻酰基]-GlcNAc脱乙酰基,形成UDP-3-O-[(R)-3-羟基肉豆蔻酰基]葡糖胺。通过1H NMR光谱和快原子轰击质谱确定了此前未描述的UDP-3-O-[(R)-3-羟基肉豆蔻酰基]葡糖胺中间产物的共价结构。在没有脂肪酰基供体[(R)-3-羟基肉豆蔻酰基]-酰基载体蛋白的情况下,将UDP-3-O-[(R)-3-羟基肉豆蔻酰基]-GlcNAc在大肠杆菌提取物中孵育,这种物质可以积累。然而,在[(R)-3-羟基肉豆蔻酰基]-酰基载体蛋白存在的情况下,将分离得到的脱乙酰化产物[UDP-3-O-[(R)-3-羟基肉豆蔻酰基]葡糖胺]添加回大肠杆菌的无膜提取物中,该化合物会迅速转化为疏水性更强的产物UDP-2,3-二酰基-GlcN、2,3-二酰基-GlcN-1-P和O-[2-氨基-2-脱氧-N2,O3-双[(R)-3-羟基十四烷酰基]-β-D-吡喃葡糖基]-(1→6)-2-氨基-2-脱氧-N2,O3-双[(R)-3-羟基十四烷酰基]-α-D-吡喃葡糖1-磷酸(四酰基二糖-1-P),证明了它作为前体的能力。使用[乙酰基-3H]UDP-3-O-[(R)-3-羟基肉豆蔻酰基]-GlcNAc进行的体外孵育证实,在该系统中乙酰基部分以乙酸盐的形式释放,而不是作为其他乙酰衍生物。脱乙酰化反应受到1 mM N-乙基马来酰亚胺的抑制,而随后的N-酰化反应则不受影响。我们的观察结果提供了强有力的证据,表明UDP-3-O-[(R)-3-羟基肉豆蔻酰基]葡糖胺是UDP-2,3-二酰基-GlcN和脂多糖A生物合成中的一个真正中间产物。